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Summary Experiments on s.c. rat tumours (DS sarcoma) were performed to determine whether chronic or
acute changes in tumour perfusion necessarily lead to changes in tissue oxygenation and bioenergetic status
since, as a rule, blood flow is thought to be the ultimate determinant of the tumour bioenergetic status. Based
on this study, there is clear experimental evidence that growth-related or acute (following i.v. administration of
tumournecrosis factor a) decreases in tumour blood flow are accompanied by parallel alterations in tissue
oxygenation. In contrast, tumour energy status remains stable as long as flow values do not fall below
0.4-0.5 ml g'min-', and provided that glucose as the main substrate can be recruited from the enlarged interstitial compartment. Perfusion rate seems to play a paramount role in determining energy status only in
low-flow tumours or low-flow tissue areas.
There is an increasing body of experimental evidence
available suggesting that 'chronic' decreases in tumour blood
flow and/or tissue oxygenation during tumour growth or
acute declines in the tissue perfusion upon therapeutic
measures are accompanied by a significant energy depriva-
tion. Strong positive correlations between energy status and
tumour perfusion or tissue oxygenation have been described
for several murine tumour systems (e.g. Lilly et al., 1985;
Evelhoch et al., 1986; Tozer et al., 1987; Vaupel et al., 1989a,
b; Steen & Graham, 1991). These investigations led to the
conclusion that blood flow may ultimately determine the
bioenergetic status of tumours during growth. Any studies
investigating changes in the energy status in tumours induced
by physical, chemical or biological manoeuvres should thus
be cognisant of alterations in blood flow. Changes in tumour
blood flow following vasodilators (Okunieff et al., 1989a;
Tozer et al., 1990), high-dose hyperthermia (Sijens et al.,
1987; Kruger et al., 1991; Mayer et al., 1992), tumour nec-
rosis factor a (TNF-a), lymphotoxin or interleukin 1 (Con-
stantinidis et al., 1989; Kluge et al., 1992), X-irradiation
(Tozer et al., 1989) or after i.p. mannitol administration
(Okunieff et al., 1989b) are always followed by parallel alter-
ations in tumour energy status. The only exception to this
rule seems to be the constant energy status found after i.p. or
i.v. glucose administration when stable or even transiently
improved energy status is observed (Okunieff et al., 1989b;
Kruger et al., 1991; Mayer et al., 1992; Schaefer et al., 1993).
Under conditions in which blood flow through a tumour is
substantially reduced, hyperglycaemia (and elevated tissue
glucose levels) can maintain high-energy phosphates at
relatively constant levels, as has been shown in several
tumour lines. Similar dissociations between changes in blood
flow and alterations of the energetic status have been
observed recently in normoglycaemic mice following
photodynamic therapy. At similar drops in blood flow to
approximately 10% of the control value, the decrease in
high-energy phosphates in a human tumour xenograft (HT
29) was significantly less than in RIF-1 tumours (Bremner et
al., 1993). The reduction in the oxygenation status caused by
hydralazine is insufficient for detection by 31P-NMR in
human xenografted tumours, whereas in RIF-1, SCCVII/Ha
and KHT murine tumours large increases in the Pi/total
phosphate ratio are found (Bremner et al., 1991; Adams et
al., 1992). In the light of these discrepancies, a number of
relevant issues need to be clarified regarding the relationship
between energy status and tumour blood flow. In the present
study, the key questions were as follows:
(1) Do changes in tumour blood flow necessarily lead to
changes in the bioenergetic status during normoglycaemia?
(2) Is there a range of tumour blood flow rates over which
the energy status is not affected by perfusion changes?
(3) Is there a critical threshold below which a positive
correlation between flow and energy status may exist?
Materials and methods
Animals, tumours andsurgicalprocedures
Sprague-Dawley rats (Charles River Wiga, Sulzfeld, Ger-
many; body weight: 310 ± 5 g) were used for experiments.
Animals were allowed access to food and water (pH 4.0) ad
libitum prior to experiments. Experimental tumours were
grown subcutaneously after injection of ascites cells of DS
sarcoma into the hindfoot dorsum (Kluge et al., 1992).
Once tumours reached the desired size, animals were
anaesthetised with sodium pentobarbital (40 mg kg-' i.p.,
Nembutal, Ceva, Paris, France). Catheters were then sur-
gically placed into the thoracic aorta via the left common
carotid artery and into the right externaljugular vein. During
surgical procedures and throughout all experiments, the
animals were placed supine on a heated operation pad (rectal
temperature t37'C), such that tumour temperature was
maintained within the range 34-36°C throughout all
experiments. In order to monitor the mean arterial blood
pressure (MABP) continuously, the arterial catheter was con-
nected to a Statham pressure transducer (type P .23 ID,
Gould, Oxnard, CA, USA). Animals breathed room air
spontaneously. Oxygen (Po2) and carbon dioxide (Pco2) par-
tial pressures and pH were determined in arterial blood
samples (50 ,.l) at regular time intervals.
Relevant parameters describing tumour perfusion,
bioenergetic and oxygenation status were measured either
during growth of the s.c. tumours ('chronic' decrease of
tumour blood flow) or following acute changes in tissue
perfusion. In the latter case, TNF-a was applied in order to
induce a significant flow drop within a short period of
time.
Measurement of tumour bloodflow
Tumour blood flow (TBF) was studied using the 8"Kr
clearance technique. For TBF measurements the indicator
(0.1 ml of a solution of 85Kr in 0.9% sodium chloride,
37 MBqml-', Amersham-Buchler, Braunschweig, Germany)
was applied as a bolus injection through the arterial catheter
into the thoracic aorta. The registration of the washout
process was performed with a Geiger-counting tube con-
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nected to a ratemeter (FHT 1100 FAG Kugelfischer, Erlangen,
Germany). The method of evaluation of TBF was identical
to that described earlier (Kluge et al., 1992). Measurements
were performed on tumours of varying sizes at 20 min inter-
vals before application of TNF-x and at 30 min intervals
thereafter over a total time period of 2 h post treatment. In
all experiments performed in this study, animals were allowed
to stabilise following the surgical procedures. Measurements
commenced once constant baseline readings for MABP and
flow were obtained for at least 20 min.
Laser Dopplerflowmetry
A Periflux model PF 3 dual-channel laser Doppler flowmeter
was used for this study (2 mW He-Ne laser, wavelength
632.8 nm; Perimed, Stockholm, Sweden). Laser Doppler flow
(LDF) signals were continuously recorded from central loca-
tions on the tumour surface using a type PF 108 probe. The
fibreoptic probe was placed above (but not in contact with)
the tumour tissue under study. LDF was recorded for 10 min
before i.v. administration of TNF-o or saline (control) and
for 90 min thereafter (Kluge et al., 1992).
Tumour oxygen tension measurements
Tumour oxygen tension values were determined using
polarographic needle electrodes (recessed 12 lam gold in glass
cathode; shaft diameter 250pLm) and P02 histography (model
KIMOC-6650, Eppendorf, Hamburg, Germany) as described
previously (Vaupel et al., 1989a, 1991). Measurements were
made either on tumours of varying sizes or before and
120 min after acute flow changes upon TNF-a application.
Measurement ofglobal concentrations ofadenylatephosphates
inperchloric acid extracts
In order to obtain mean (global) levels of adenylate phos-
phates, the tumour-bearing hindfoot was rapidly frozen and
the tumours (n = 12) were prepared under liquid nitrogen
and stored at -80°C for further processing. In a first series
of experiments, tumours of varying sizes were analysed. In
another series, tumours were assayed before or 120 min after
administration of TNF-o.
Each deep-frozen tumour was ground to a fine powder and
freeze dried. For determination of ATP, ADP and AMP
levels, aliquots of freeze-dried tissue were extracted with
0.66 M perchloric acid, centrifuged and the supernatant neut-
ralised with 2 M potassium hydroxide. The concentrations of
the adenylate phosphates were then determined using
reversed-phase high-performance liquid chromatography
(HPLC) techniques at 254 nm (for more details see Kruger et
al., 1991; Schaefer et al., 1993). Concentrations were ex-
pressed as j.mol per g tissue wet weight.
Determination ofmicroregional ATP distribution
Before preparing the rapidly frozen tumours for HPLC
analysis, approximately 30% of the tumour mass was
separated, cut at -25°C in a cryostat into 5-nm sections and
used for ATP bioluminescence measurements to assess the
microregional ATP distribution using single-photon imaging
and quantitative bioluminescence (for methodological details
see Walenta et al., 1992; Schaefer et al., 1993). The spatial
resolution gained by this method is about 50jam, thus reveal-
ing information about the intra-tumour variability of the
ATP levels in relation to histological details.
Introduction ofacuteflow drops through TNF-c
Recombinant human TNF-x (specific activity: 8.2 x
106 U per mg of protein; Knoll, Ludwigshafen, Germany)
was diluted in isotonic phosphate-buffered saline solution
containing 0.5% (w/w) bovine serum albumin (Sigma
Chemie, Deisenhofen, Germany). TNF-ao was given into the
external jugular vein at a dose level of 1 mg kg-' over app-
roximately 3 min. The catheter used for the i.v. route was
flushed with saline thereafter. Control animals received iden-
tical fluid loads (1 ml kg-' phosphate-buffered saline i.v.).
For further details see Kluge et al. (1992).
Statistical analysis
Results are expressed as means ± s.e. with the numbers of
experiments indicated in brackets. Significance was assessed
using the paired or unpaired Student's t-test, as appropriate.
Results were considered as significant if P-values were less
than 5% (P<0.05).
Results and Discussion
Like many other experimental tumour systems, tumour blood
flow (TBF) and tissue oxygenation significantly decrease in
the DS sarcoma with increasing tumour mass (see Figure 1).
Starting from a mean TBF value of 0.98 ml g-1 min-' in the
smallest tumours investigated, flow decreased by about 50%
in the larger malignancies (2P<0.001). This flow drop coin-
cides with a similar decrease in the mean Po2 value from 39
to 16mmHg (2P<0.001).
As long as tumour masses do not exceed 1% of the body
weight (i.e. biologically relevant tumour sizes), global ATP
concentrations and adenylate energy charge remain almost
constant. During tumour growth from 0.86 ± 0.02 to
2.15 ± 0.04 g, ATP concentrations insignificantly increased
from 1.15 ± 0.10 to 1.37 ± 0.12jtmol g-'. Similar results were
obtained when the microregional ATP distribution was
analysed in three tissue sections of three tumours each of
three different size groups (mean tumour weights:
0.82±0.08g, 1.25±0.10g and 2.14±0.12g; see Figure
1).
Flow and P02 values in these tumour size ranges are
similar to those observed in many normal tissues (Vaupel et
al., 1989c) and are seen to be accompanied by a stable energy
status. Changes in TBF can influence tissue oxygenation but
not ATP concentrations in this tissue. This may be explained
by an intensified glycolytic rate as the oxygenation status
deteriorates and/or a decreasing number of proliferating cells
which compensate for the poorer oxygen supply as the
tumours become larger. As long as TBF and/or P02 values
do not fall below a certain 'threshold', tumour energy status
can be maintained. Under these conditions, glucose has to be
considered as the major energy source, which is available in
sufficient amounts even under normoglycaemic conditions.
Owing to the large interstitial space of those tumours [app-
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Figure 1 Tumour growth-related changes in tumour blood flow
(TBF, open circles) and mean tissue oxygen tension (P02, closed
circles) and mean tumour tissue ATP concentrations as deter-
mined by HPLC in perchloric acid extracts (open triangles) or
quantitative bioluminescence (closed triangles). Values in paren-
theses indicate the numbers of tumours investigated. Values are
means ± s.e. Standard errors of tumour wet weights are within
the symbol sizes.
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roximately 50% (v/v); Gullino et al., 1965; Vaupel & Miiller-
Klieser, 1983; Stubbs et al., 1992], the mean tissue glucose
concentration is > 1.5 gmol g-1 ('reservoir function' of the
interstitial space). The missing decrease in high-energy phos-
phates despite severe restrictions in tumour blood flow dur-
ing hyperglycaemia as observed in rodent tumours supports
this notion (Okunieff et al., 1989b; Kruger et al., 1991;
Schaefer et al., 1993). In line with these findings is a recent
study of Gerweck et al. (1993) showing that energy status
and oxygenation are not closely linked in the presence of
glucose.
Similar observations have been described for other experi-
mental tumour systems. In an amelanotic hamster melanoma
(A-Mel-3), ATP concentrations remained constant as long as
blood flow values were above 0.4 ml g' min-' (Walenta et
al., 1992). This finding is based on pixel-to-pixel correlations
between microregional ATP concentrations and flow data.
In murine FSaII tumours, median P02 values of
10-15 mmHg represent a critical threshold for energy
metabolism (Vaupel et al., 1993). At higher median P02
values, ATP levels were relatively constant. On average,
median oxygen tensions below 10-15 mmHg coincided with
ATP depletion, intracellular acidosis, a drop in the energy
charge and rising Pi levels (Vaupel, 1992). These conditions
were, however, only found when tumour masses were
> 1.5% of body weight.
Stable bioenergetic status is observed not only during
'growth-related' decreases in blood flow or tissue P02 values,
but also upon acute falls in TBF following TNF-a adminis-
tration. This cytokine is known to drastically reduce micro-
circulatory function (Kluge et al., 1992; Naredi et al., 1993).
Starting from TBF values of0.98 ± 0.05 ml g-' min-' (tumour
wet weights: 0.85 ± 0.05 g), TNF-x application resulted in a
50% flow drop within 120 min (Figure 2). Similar changes
were observed for the tumour P02 distribution. Despite these
substantial changes, ATP levels, phosphocreatine (PCr)/Pi and P-nucleoside triphosphate (I3-NTP)/Pi ratios remained
almost unchanged*.
Here again, energy status was stable at mean flow values
0.5 ml g-'min-1, mean oxygen tensions > 13 mmHg and
mean tumour tissue glucose levels > 1.4iLmolg-' (Engel &
Vaupel, 1993). From the data presented it is concluded that
growth-related or acute changes in tumour perfusion are, as
a rule, accompanied by parallel alterations of tissue oxygena-
*PCr/Pi and NTP/Pi ratios were obtained from 31P-NMR spectro-
scopy (Kluge et al., 1992) using the same experimental protocol (B.
Elger et al., unpublished data).
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Figure 2 Acute effects of TNF-oc (1 mgkg-'I i.v.) on tumour
blood flow (TBF, open circles, n = 28), laser Doppler flow (LDF,
closed circles, n = 6), mean oxygen partial pressure in tumour
tissue (Po2, open triangles, n =12), tumour tissue ATP concent-
rations (closed triangles, n = 12) and 3'P-magnetic resonance
spectroscopy-derived PCr/P, (closed squares), and P-NTP/P, ratios
(open squares, n = 5). Values are means ± s.e.
tion. In contrast, tumour energy status is stable providing
flow values do not fall below a certain threshold (approx-
imately 0.4-0.5 ml g-'min-' in the rodent tumour systems
investigated). As compensatory mechanisms, an intensified
glycolysis due to the recruitment of glucose from the 'interst-
itial reservoir' and a decrease in the number of proliferating
cells, have to be assumed.
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